The results of the SURPASS-2 clinical trial evaluating the effects of tirzepatide in patients with type 2 diabetes showed that the trial treatment resulted...
INDIANAPOLIS, June 26, 2021 /PRNewswire/ -- Tirzepatide led to superior A1C and body weight reductions from baseline across all three doses in adults with type...